 This study found that the coverage of mass drug administration MD for lymphatic fileruses was 83.5% while the compliance was 75.9%. The effective coverage rate was only 63.4% indicating that there is still room for improvement. Additionally, the study found that the knowledge regarding fileruses and MD was 82% and 59% respectively among the beneficiaries. Furthermore, all the drug distributors had knowledge about both the fileruses and MDA. Therefore, it is important to continue to educate the target population on the importance of MDA and the elimination of lymphatic fileruses. This article was authored by H.S. Ravish, Malatish Undi and A.R. Rachna.